Biomarin Pharmaceutical - Registered Shares Net Tangible Assets

As of the most recent data (June 2026), BMRN shows a net tangible assets of $6.3B. That compares with $6B in the prior-year period — up 4.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BMRN's net tangible assets is now $6.3B (was $6B) — a 4.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Biomarin Pharmaceutical - Registered Shares is outperforming or lagging.

Tracking BMRN's net tangible assets over time shows whether Biomarin Pharmaceutical - Registered Shares is scaling, shrinking, or reshaping that part of the business. The current reading is $6.3B That compares with $6B in the prior-year period — up 4.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Biomarin Pharmaceutical - Registered Shares's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $6.3B) with ownership activity and broader fundamentals.

Biomarin Pharmaceutical - Registered Shares's net tangible assets is $6.3B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.